Stochastic hypothesis of transition from inborn neutropenia to AML: Interactions of cell population dynamics and population genetics

Frontiers in Oncology

Volumn 3 APR, Issue , 2013, Pages

  Kimmel, Marek ^a   Corey, Seth ^b  

^a Rice University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia; Branching process; Clonal evolution; Driver mutations; Myelodysplastic syndrome; Severe congenital neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL CLONE; CELL DIFFERENTIATION; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CLONAL EVOLUTION; GENE MUTATION; GROWTH ACCELERATION; LEUKEMIA CELL; MUTATION RATE; MYELODYSPLASTIC SYNDROME; POPULATION DYNAMICS; POPULATION GENETICS; PROBABILITY; SEVERE CONGENITAL NEUTROPENIA; SIMULATION; STOCHASTIC MODEL;

EID: 84890764282     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00089     Document Type: Article

References (22)

1. Beekman, R., and Touw, I. P. (2010). G-CSF and its receptor in myeloid malignancy. Blood 115, 5131-5136.
2. Beekman, R., Valkhof, M. G., Sanders, M. A., van Strien, P. M., Haanstra, J. R., Broeders, L., et al. (2012). Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 119, 5071-5077.
3. Bender, J. G., Unverzagt, K., Walker, D. E., Lee, W., Smith, S., Williams, S., et al. (1994). Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin. Immunol. Immunopathol. 70, 10-18.
4. Bhatia, S. (2011). Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors. Cancer Epidemiol. Biomarkers Prev. 20, 2048-2067.
5. Bonnet, J., and Dick, J. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
6. Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., et al. (2010). Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. U.S.A. 107, 18545-18550.
7. Carlsson, G., Fasth, A., Berglöf, E., Lagerstedt-Robinson, K., Nordenskjöld, M., Palmblad, J., et al. (2012). Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Br. J. Haematol. 158, 363-369.
8. Cyran, K. A., and Kimmel, M. (2010). Alternatives to the Wright-Fisher model: the robustness of mitochondrial Eve dating. Theor. Popul. Biol. 78, 165-172.
9. Dedeepiya, V. D., Rao, Y. Y., Jayakrishnan, G. A., Parthiban, J. K., Baskar, S., Manjunath, S. R., et al. (2012). Index of CD34+ cells and mononuclear cells in the bone marrow of spinal cord injury patients of different age groups: a comparative analysis. Bone Marrow Res. 2012, 787414.
10. Donadieu, J., Leblanc, T., Bader, M. eunierB., Barkaoui, M., Fenneteau, O., Bertrand, Y., et al. (2005). Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90, 45-53.
11. Dong, F., Brynes, R. K., Tidow, N., Welte, K., Lowenberg, B., and Touw, I. P. (1995). Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333, 487-493.
12. Germeshausen, M., Ballmaier, M., and Welte, K. (2007). Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 109, 93-99.
13. Glaubach, T., and Corey, S. J. (2012). From famine to feast: sending out the clones. Blood 119, 5063-5064.
14. Griffiths, R. C., and Pakes, G. (1988). An infinite-alleles version of the simple branching process. Adv. Appl. Probab. 20, 489-524.
15. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
16. Kimmel, M., and Axelrod, D. E. (2002). Branching Processes in Biology. New York: Springer.
17. Kimmel, M., and Mathaes, M. (2010). Modeling neutral evolution of Alu elements using a branching process. BMC Genomics 11(Suppl. 1), S11. doi:10.1186/1471-2164-11-S1-S11
18. Michor, F., Iwasa, Y., and Nowak, M. A. (2004). Dynamics of cancer progression. Nat. Rev. Cancer 4, 197-205.
19. Rosenberg, P. S., Alter, B. P., Bolyard, A. A., Bonilla, M. A., Boxer, L. A., Cham, B., et al. (2006). The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107, 4628-4635.
20. Rosenberg, P. S., Zeidler, C., Bolyard, A. A., Alter, B. P., Bonilla, M. A., Boxer, L. A., et al. (2010). Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br. J. Haematol. 150, 196-199.
21. Walter, M. J., Shen, D., Ding, L., Shao, J., Koboldt, D. C., Chen, K., et al. (2012). Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366, 1090-1098.
22. Whichard, Z. L., Sarkar, C. A., Kimmel, M., and Corey, S. J. (2010). Hematopoiesis and its disorders: a systems biology approach. Blood 115, 2339-2347.